Biochemical characterization of a novel Fragile X Mental Retardation Protein nuclease function
Biochemical characterization of a novel Fragile X Mental Retardation Protein nuclease function
批准号:
10359289
负责人:
MIHAELA R MIHAILESCU
金额:
$41.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2024-08-31
关键词:
2019-nCoV3&apos Untranslated RegionsActive SitesAffectAffinityAmino AcidsAntiviral AgentsArginineBindingBiochemicalBiogenesisBiologicalBiological AssayBiological ProcessC-terminalCOVID-19 pandemicCleaved cellComplexDNADependenceDevelopmentDimerizationFMR1FXR1 geneFXR2 geneFemaleFluorescence SpectroscopyFragile X SyndromeG-QuartetsGenomeGlycineGuide RNAHomodimerizationHybridsImmune responseIndividualInheritedInvestigationIonsKH DomainKineticsLiteratureMass Spectrum AnalysisMessenger RNAMicroRNAsModelingN-terminalNamesNorthern BlottingNucleotidesPathway interactionsPhosphorylationPlayPoint MutationProcessPropertyProtein BiosynthesisProteinsPsyche structureRNARNA InterferenceRNA Recognition MotifRNA VirusesRNA-Binding ProteinsRecombinantsRegulationReportingRoleSARS-CoV-2 antiviralSARS-CoV-2 genomeSARS-CoV-2 infectionSpecificityStructureSynapsesSyndromeSystemTertiary Protein StructureTestingTranslationsUntranslated RNAViralVirusWorkZIKV infectionZika Virusgenomic RNAmalenovelnucleaseparalogous geneprotein functionquadruplex DNAresponsestem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Fragile X mental retardation syndrome is the most common form of inherited mental impairement, affecting ~ 1
in 4000 males and ~ 1 in 6000 females. The syndrome is caused by the loss of a normal cellular protein, named
the fragile X mental retardation protein (FMRP). FMRP is an RNA binding protein involved in the transport and
translation regulation of specific messenger RNA (mRNA) targets. The mechanisms by which FMRP exerts its
translation regulator function are not known, however it has been proposed that the protein works in conjunction
with the microRNA (miRNA) pathway to regulate local protein synthesis in response to synaptic input. We have
determined that FMRP has nuclease activity, being able to process precursor microRNAs (pre-miRNAs),
potentially being involved in the mature miRNA biogenesis. This proposal, which will characterize this novel
FMRP function, has the following specific aims:
AIM I. Identification of the FMRP domain(s) responsible for its nuclease activity. We hypothesized that the
FMRP nuclease activity resides in one of his K homology domains and to test this hypothesis we will produce
several FMRP constructs lacking one or more of these domains. We determined that phosphorylated FMRP has
higher nuclease efficiency than the unphosphorylated FMRP and we will test if this is caused by their different
dimerization properties. Finally, we will also test if the FMRP paralogs, FXR1P and FXR2P, which share with
FMRP the KH0, KH1 and KH2 domains, also have nuclease activity.
AIM II. Biochemical characterization of the FMRP nuclease activity. We will determine if the pre-miRNA
FMRP and its phosphorylated mimic can cleave pre-miRNAs into mature miRNAs. Additionally, we will determine
if FMRP has additional substrates for its nuclease activity such as RNA perfect duplex, RNA single strand, RNA
G quadruplex, DNA-RNA hybrid duplex, DNA duplex. Finally, we will characterize the kinetics of the FMRP
nuclease.
AIM III. Investigation of the FMRP interactions with the SARS-CoV-2 3’-UTR genome and of the potential
role played by its nuclease activity in this viral system. Similar to its demonstrated role of restrictive factor
in ZIKA virus infection, it has been proposed that FMRP might play a role in the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, the virus responsible for the current COVID-19 pandemic. We
will test if FMRP cleaves various stem-loops within the SARS-CoV-2 RNA genomic 3’-untranslated region using
its nuclease function either to potentially yield viral miRNAs or functioning in the antiviral host response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Backbone Modified Peptide-nucleic Acids as Antiviral Agents Against Hepatitis C
-
批准号:8253898
-
项目类别:
-
资助金额:$6.2万
-
财政年份:2012
-
负责人:MIHAELA R MIHAILESCU
-
依托单位:
Functional studies of the Fragile X Mental Retardation Protein: switching from re
-
批准号:7934339
-
项目类别:
-
资助金额:$12.4万
-
财政年份:2009
-
负责人:MIHAELA R MIHAILESCU
-
依托单位:
G quartet RNA-FMRP interactions in Fragile X syndrome
-
批准号:6954409
-
项目类别:
-
资助金额:$21.01万
-
财政年份:2005
-
负责人:MIHAELA R MIHAILESCU
-
依托单位:
Fragile X Mental Retardation Protein translation regulator function: interactions
-
批准号:8494883
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2005
-
负责人:MIHAELA R MIHAILESCU
-
依托单位:
Investigation of Fragile X mental retardation protein interactions with the miRNA pathway.
-
批准号:9303733
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2005
-
负责人:MIHAELA R MIHAILESCU
-
依托单位:
Biochemical characterization of a novel Fragile X Mental Retardation Protein nuclease function
-
批准号:10793981
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2005
-
负责人:MIHAELA R MIHAILESCU
-
依托单位:
国内基金
登录
查看更多内容
3'-甲氧基葛根素生物合成途径中关键甲基转移酶基因的克隆与功能分析
-
批准号:31300258
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:黎佳
-
依托单位:
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
-
批准号:81300507
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2013
-
负责人:陈黎
-
依托单位:
3'-UTR单核苷酸多态性影响CYP8B1基因表达致胆囊胆固醇结石形成的机制研究
-
批准号:81370561
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:秦俭
-
依托单位:
异源杂交多倍化鲫鲤特有性状的转录组及后转录组水平变化规律研究
-
批准号:31360514
-
项目类别:地区科学基金项目
-
资助金额:54.0万元
-
批准年份:2013
-
负责人:罗静
-
依托单位:
HIF基因3'UTR区SNP参与胰腺癌HIF-1α表达调控的分子机制及功能研究
-
批准号:81302082
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王秀超
-
依托单位:
鼻咽癌转移相关通路分子的microRNA调控机制及3'UTR区可变剪切的作用研究
-
批准号:81372886
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:买世娟
-
依托单位:
小鼠精原干细胞中APA位点研究及3'UTR使用频率数据库构建
-
批准号:31301085
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2013
-
负责人:熊远妍
-
依托单位: